Evidence map›Paper›PMID 40789160›Full record

ArticleBiology open2025

Steroid 21-hydroxylase deficiency dysregulates essential molecular pathways of metabolism and energy provision.

Irina Bacila, Lara Oberski, Nan Li, Karl-Heinz Storbeck, Vincent T Cunliffe, Nils Krone

Abstract read
In one paragraph

Article in Biology open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Irina BacilaDepartment of Clinical Sciences, School of Medicine and Population Health, University of Sheffield, Sheffield S10 2RX, UK.
Lara OberskiDepartment of Clinical Sciences, School of Medicine and Population Health, University of Sheffield, Sheffield S10 2RX, UK.
Nan LiDepartment of Clinical Sciences, School of Medicine and Population Health, University of Sheffield, Sheffield S10 2RX, UK.
Karl-Heinz StorbeckDepartment of Biochemistry, Stellenbosch University, Ryneveld Street Stellenbosch 7600, Matieland, South Africa.
Vincent T CunliffeDepartment of Development, Regeneration and Neurophysiology, School of Biosciences, University of Sheffield, Firth Court, Western Bank, Sheffield S10 2TN, UK.
Nils KroneDepartment of Clinical Sciences, School of Medicine and Population Health, University of Sheffield, Sheffield S10 2RX, UK.ORCID 0000-0002-3402-4727

Funding

Deutsche Forschungsgemeinschaft KR 3363/3-1Society for EndocrinologySociety for Endocrinology ECGThe University of Sheffield
6 · The paper itself

Abstract

The prevalence of metabolic disease is increased in congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency. However, the underlying molecular mechanisms causing these problems are not fully understood. We aimed to elucidate the metabolic phenotype and conduct a transcriptomic analysis of a 21-hydroxylase-deficient zebrafish model, to unravel the molecular mechanisms underlying the metabolic pathophysiology of CAH. The morphology, anatomy and transcriptomic analysis of whole larvae, adult liver tissue from 18-month-old cyp21a2-/- zebrafish were compared to those of wild-type siblings. Our main phenotypical finding was that adult mutants were larger, with increased fat deposition compared to controls, in-keeping with the transcriptomic analysis showing the dysregulation of several biological processes involved in lipid metabolism. Importantly, we found that ATP synthesis and provision of energy precursors were included among the most significantly suppressed processes in both larvae and adult livers. We conclude that cortisol deficiency in cyp21a2-/- mutants causes growth and body fat abnormalities at adult stages, as well as transcriptomic dysregulation of metabolic processes, energy homeostasis and inflammatory responses in both larvae and adults. These findings reveal how GC deficiency in zebrafish contributes to the development of the metabolic comorbidities that are similar to those observed in patients with CAH.

Indexed as

Adrenal Hyperplasia, CongenitalEnergy MetabolismMetabolic Networks and PathwaysSteroid 21-HydroxylaseAnimalsDisease Models, AnimalGene Expression ProfilingLipid MetabolismLiverMutationPhenotypeTranscriptomeZebrafishSteroid 21-HydroxylaseAdrenal diseaseMetabolic dysregulationsSteroid 21-hydroxylase deficiencyZebrafish

Identifiers

PMID40789160
PMCPMC12452057

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.